EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The hexosamine biosynthetic pathway drives tumor immune evasion via translational control of PD-L1 at the elongation level

Bo Liu, Yingying Wu, Anyi Xiang, Yiyi Yu, Shushu Song, Ying Zhang, Jianxin Gu, Haojie Lu, Ping Xu, Fenglin Liu, Yuanyuan Ruan

Cell Reports · 2025

DOI: 10.1016/j.celrep.2025.116249 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2025. Verfasst von Bo Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Laboratory of Glycoconjugates Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences and Second Departm…. Hauptthemen laut MEDLINE: B7-H1 Antigen, Hexosamines, Tumor Escape, Biosynthetic Pathways. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fudan University, National Natural Science Foundation of China, National Center for Protein Sciences, Peking University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

T lymphocyte infiltration in a colorectal cancer model. GFAT1 induced the expression of the immune checkpoint PD-L1 at the translational level by bypassing signal peptide-mediated translation elongation arrest. Proteomic and glycoproteomic screening indicated that GFAT1 facilitated the N-linked glycosylation and protein expression of integrin α2/α3 subunits, leading to FAK activation and elongation factor eEF1A2 upregulation. Pharmacological inhibition of HBP noticeably enhanced the efficacy of immune checkpoint blockade in vivo. Together, these findings unravel how immune checkpoint proteins are manipulated by metabolic dysregulation, which can be exploited as metabolic vulnerability for improving immunotherapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B7-H1 AntigenHexosaminesTumor EscapeBiosynthetic PathwaysProtein BiosynthesisAnimalsHumansMiceCell Line, TumorMice, Inbred C57BLGlycosylationColorectal Neoplasms

Stichwörter der Autor:innen

CP: CancerPD-L1glycosylationhexosamine biosynthetic pathwayimmune evasionprotein synthesis

Substanzen

B7-H1 AntigenHexosaminesCD274 protein, human

Autor:innen und Institutionen

  • NHC Key Laboratory of Glycoconjugates Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences and Second Department of Gastric Surgery, Shanghai Cancer Center, Fudan University, Shan…
  • Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • NHC Key Laboratory of Glycoconjugates Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.
  • NHC Key Laboratory of Glycoconjugates Research, School of Basic Medical Sciences and Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, China. Electronic address: ying@fudan.edu.cn.

Förderung

  • Fudan University
  • National Natural Science Foundation of China
  • National Center for Protein Sciences, Peking University
  • National Key Research and Development Program of China

Zitieren

APA

Liu, B., Wu, Y., Xiang, A., Yu, Y., Song, S., Zhang, Y., Gu, J., Lu, H., Xu, P., Liu, F., & Ruan, Y. (2025). The hexosamine biosynthetic pathway drives tumor immune evasion via translational control of PD-L1 at the elongation level. Cell Reports. https://doi.org/10.1016/j.celrep.2025.116249

Vancouver

Liu B, Wu Y, Xiang A, Yu Y, Song S, Zhang Y, et al. The hexosamine biosynthetic pathway drives tumor immune evasion via translational control of PD-L1 at the elongation level. Cell Reports. 2025. doi:10.1016/j.celrep.2025.116249

BibTeX
@article{Liu2025,
  author = {Liu, Bo and Wu, Yingying and Xiang, Anyi and Yu, Yiyi and Song, Shushu and Zhang, Ying and Gu, Jianxin and Lu, Haojie and Xu, Ping and Liu, Fenglin and Ruan, Yuanyuan},
  title = {The hexosamine biosynthetic pathway drives tumor immune evasion via translational control of PD-L1 at the elongation level},
  journal = {Cell Reports},
  year = {2025},
  doi = {10.1016/j.celrep.2025.116249}
}
Kostenlos starten →